The Global Ophthalmoplegia Market Driven By Increasing Cases Of Neurological Disorders

By Author: colin
Total Articles: 197
Comment this article

The Global Ophthalmoplegia Market involves disorders related to eye movements caused by problems affecting nerve pathways or muscles that control the eye movement. Ophthalmoplegia can result from problems in various parts of the brain or neuromuscular junction that controls eye movement. Some common causes of ophthalmoplegia include myasthenia gravis, nerve damage from tumors, multiple sclerosis, stroke, and traumatic brain injury. The treatments for ophthalmoplegia involve medications such as anticholinesterase inhibitors, immunosuppressants, corticosteroids depending on the underlying condition. Surgeries such as strabismus surgery and recession procedures are also performed in some cases.
The Global Ophthalmoplegia Market is estimated to be valued at US$ 510 Mn in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the Global Ophthalmoplegia Market include Novartis AG, Sanofi, F. Hoffmann-La Roche Ltd., Pfizer Inc., Bayer AG. Novartis AG and Sanofi dominate the market with their wide product portfolio for the treatment of neurological ...
... disorders causing ophthalmoplegia.
The growing prevalence of neurological illnesses such as myasthenia gravis, multiple sclerosis, stroke is a major factor fueling the demand for ophthalmoplegia treatments. According to some estimates, neurological disorders affect over 1 billion people worldwide annually.
The key market players are expanding their presence globally especially in developing regions of Asia Pacific and Latin America through new product launches, partnerships and acquisitions. For instance, Novartis AG launched multiple sclerosis drug Mayzent in countries like China and Brazil in 2021.
Market Drivers
The increasing cases of neurological disorders is a key growth driver for the global ophthalmoplegia market. According to the National Institute of Neurological Disorders and Stroke (NINDS), more than 1,000 new cases of neurological disorders are diagnosed daily in the United States alone. The rising mental health burden linked to the COVID 19 pandemic has further contributed to the neurological caseload globally. This growing incidence of neurological illnesses will spur the demand for effective drugs and treatments for ophthalmoplegia complications. Other factors such as growing geriatric population, increasing access to healthcare in emerging countries, and advances in eye surgery technologies will also support the ophthalmoplegia market expansion during the forecast period.
With the ongoing geopolitical uncertainties and global conflicts, supply chain disruptions have become a major challenge for the global ophthalmoplegia market. The market was earlier concentrated in North America and Europe owing to strong healthcare infrastructure and availability of advanced treatment options in these regions. However, the ongoing Russia-Ukraine war has significantly impacted pharmaceutical supply chains and medical device trade across Eastern Europe. This is expected to hamper the future growth prospects of the ophthalmoplegia market in these regions.
Moreover, supply chain constraints due to lockdowns in China and rising input costs have made it difficult for key market players to ensure consistent supply of ophthalmoplegia drugs and devices to other parts of the world. Looking ahead, companies operating in the ophthalmoplegia market need to extensively diversify their supplier networks and focus on building strategic inventories. Adopting a multi-sourcing model can help minimize risks of supply interruptions caused due to geopolitical conflicts or logistic challenges. Companies may also need to explore new manufacturing hubs in other low-cost regions like Latin America and Southeast Asia.
In terms of geographical markets, North America currently accounts for the largest share of the global ophthalmoplegia market, both in terms of value and volume. This is attributed to growing prevalence of eye disorders and increasing adoption of new treatment therapies in the US and Canada. Within North America, the US healthcare market represents highest revenues for ophthalmoplegia drugs and devices. Moving forward, the Asia Pacific region is expected to witness fastest growth on the back of rising medical tourism, growing geriatric population and increasing healthcare spending in major countries like China and India.
Get more insights on this topic:https://colinwilson11.hashnode.dev/the-global-ophthalmoplegia-market-will-gain-traction-owing-to-increasing-diagnosis-rate

About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
What Are The Key Data Covered In This Global Ophthalmoplegia Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Global Ophthalmoplegia Market's growth between 2024 and 2031.
:- Accurate calculation of the size of the Global Ophthalmoplegia Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Global Ophthalmoplegia Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market's competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Global Ophthalmoplegia Market vendors
FAQ’s
Q.1 What are the main factors influencing the Global Ophthalmoplegia Market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Global Ophthalmoplegia Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Global Ophthalmoplegia Market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it